BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2019
View Archived Issues
Their antiviral work done, T cells go rogue
Read More
Clinical qualification of a novel P2X7-specific PET ligand in healthy volunteers
Read More
Phase III trial of tucidinostat/exemestane in advanced, HR-positive breast cancer
Read More
Sirona's SGLT2 inhibitor TFC-039 advancing through phase I trials
Read More
Protein provides protection against diabetic retinopathy
Read More
ADAMTS13 deficiency contributes to Alzheimer's disease cerebrovascular dysfunction
Read More
Phase II trial of axitinib plus pembrolizumab in patients with advanced sarcomas
Read More
Entera initiates phase II dose ranging study for oral PTH
Read More
University of Dundee and Bukwang Pharmaceutical partner to develop new treatment for PD
Read More
BST-236 demonstrates promising safety in patients with AML unfit for standard therapy
Read More
CARMIL2 variant linked to infantile onset of colitis and gastrointestinal eosinophilic disease
Read More
miRNAs and angiogenic factors as potential new biomarkers in CML
Read More
miR-451 is a potential therapeutic target for spinocerebellar ataxia type 2 treatment
Read More
FDA grants IND approval to novel PD-1/VEGF bispecific antibody for solid tumors
Read More
[177Lu]BL-01 as a radiotherapeutic agent for CXCR4-expressing lymphoma
Read More
Confo Therapeutics and DyNAbind establish GPCR drug discovery collaboration
Read More
European Commission approves Ultomiris for adults with PNH
Read More
FDA grants accelerated approval to Xpovio for relapsed refractory multiple myeloma
Read More
Synergys Biotherapeutics receives NCI funding for development of anti-HER2 antibody fusion candidate
Read More
Leo Pharma patents PDE4 inhibitors
Read More
GlaxoSmithKline identifies new IDO1 inhibitors for HIV infection
Read More
New PRMT5 inhibitors for cancer presented by Lupin
Read More
Gedeon Richter divulges vasopressin V1A receptor antagonists
Read More
VenatoRx Pharmaceuticals synthesizes HBV capsid assembly modulators
Read More
